Related Experiment Video
Updated: Apr 18, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.3K
Integrating computational chemistry and machine learning to predict KRAS mutation-induced resistance
Katarzyna Mizgalska1,2, Konstancja Urbaniak3, Denis J Imbody4
1Department of Machine Learning, Moffitt Cancer Center, Tampa, FL, United States of America.
Biorxiv : the Preprint Server for Biology
|April 17, 2026
Summary
Drug resistance in KRAS-mutant cancers can be predicted using a computational framework. This approach integrates molecular dynamics and machine learning to identify key protein changes driving resistance, achieving over 90% accuracy.
Area of Science:
- Oncology
- Computational Biology
- Biochemistry
Background:
- Mutation-induced drug resistance is a significant challenge in targeted cancer therapies, especially for KRAS-driven tumors.
- Secondary mutations in KRAS (e.g., G12C/Y96C) can confer resistance to covalent inhibitors by altering protein dynamics, even when the drug binding site remains intact.
Purpose of the Study:
- To develop a computational framework for predicting drug resistance in KRAS mutants.
- To identify structural and dynamic features that distinguish treatment-sensitive from treatment-resistant KRAS variants.
Main Methods:
- Integration of molecular dynamics simulations with machine learning algorithms (logistic regression, random forest, support vector machine, Bayesian Network).
- Extraction of molecular features including structural, energetic, thermodynamic, and contact-based descriptors from simulation data.
- Training and validation of predictive models using data from sensitive and resistant KRAS mutants.
Main Results:
- The computational framework achieved average accuracies exceeding 90% in distinguishing resistant from sensitive KRAS mutants.
- Key predictive features included solvent-accessible surface area variability, Lennard-Jones 1,4 energy, mean square displacement, and root mean square fluctuation.
- Residues G10, E62, and H95 were identified as critical sites influencing drug resistance.
Conclusions:
- Conformational and solvent-exposure changes are central mechanisms driving KRAS drug resistance.
- The developed computational workflow provides a generalizable strategy for predicting and understanding mutation-induced resistance in KRAS and other cancer targets.
